These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3356321)

  • 21. The influence of soil particle adsorption on 2,3,7,8-tetrachlorodibenzo-p-dioxin biological uptake in the rabbit.
    Bonaccorsi A; di Domenico A; Fanelli R; Merli F; Motta R; Vanzati R; Zapponi GA
    Arch Toxicol Suppl; 1984; 7():431-4. PubMed ID: 6596012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
    Leung HW; Paustenbach DJ; Murray FJ; Andersen ME
    Toxicol Appl Pharmacol; 1990 May; 103(3):399-410. PubMed ID: 2160135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical examination of assumptions used in risk assessments of dioxin contaminated soil.
    Paustenbach DJ; Shu HP; Murray FJ
    Regul Toxicol Pharmacol; 1986 Sep; 6(3):284-307. PubMed ID: 3775086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying soil cleanup criteria for dioxins in urban residential soils: how have 20 years of research and risk assessment experience affected the analysis?
    Paustenbach DJ; Fehling K; Scott P; Harris M; Kerger BD
    J Toxicol Environ Health B Crit Rev; 2006; 9(2):87-145. PubMed ID: 16613806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
    Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
    Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study on health effects of environmental 2,3,7,8-TCDD in Missouri.
    Webb K; Evans RG; Stehr P; Ayres SM
    Am J Ind Med; 1987; 11(6):685-91. PubMed ID: 3605105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of soil properties on the biodegradation of 1,3,6,8-tetrachlorodibenzo-p-dioxin and fungal treatment of contaminated paddy soil by white rot fungus Phlebia brevispora.
    Kamei I; Watanabe M; Harada K; Miyahara T; Suzuki S; Matsufuji Y; Kondo R
    Chemosphere; 2009 Jun; 75(10):1294-300. PubMed ID: 19386344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of humoral immune responses by 2,3,7,8-tetrachlorodibenzo-p-dioxin intercalated in smectite clay.
    Boyd SA; Johnston CT; Pinnavaia TJ; Kaminski NE; Teppen BJ; Li H; Khan B; Crawford RB; Kovalova N; Kim SS; Shao H; Gu C; Kaplan BL
    Environ Toxicol Chem; 2011 Dec; 30(12):2748-55. PubMed ID: 21994089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of [14C]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its effect on the vitamin A content in parenchymal and stellate cells of rat liver.
    Håkansson H; Hanberg A
    J Nutr; 1989 Apr; 119(4):573-80. PubMed ID: 2703915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Shen ES; Olson JR
    Drug Metab Dispos; 1987; 15(5):653-60. PubMed ID: 2891482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A time-dependent 2,3,7,8-tetrachlorodibenzo-p-dioxin body-burden model.
    Craig TO; Grzonka RB
    Arch Environ Contam Toxicol; 1991 Sep; 21(3):438-46. PubMed ID: 1953032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Pharmacokinetics in rats using a loading-dose/maintenance-dose regime with high doses.
    Krowke R; Chahoud I; Baumann-Wilschke I; Neubert D
    Arch Toxicol; 1989; 63(5):356-60. PubMed ID: 2818199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative toxicity and tumor-promoting ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,4,7,8-pentachlorodibenzofuran (PCDF), and 1,2,3,4,7,8-hexachlorodibenzofuran (HCDF) in hairless mice.
    Hébert CD; Harris MW; Elwell MR; Birnbaum LS
    Toxicol Appl Pharmacol; 1990 Feb; 102(2):362-77. PubMed ID: 2300974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic aryl hydrocarbon hydroxylase and cytochrome P450 induction following the transpulmonary absorption of TCDD from intratracheally instilled particles.
    Nessel CS; Amoruso MA; Umbreit TH; Gallo MA
    Fundam Appl Toxicol; 1990 Oct; 15(3):500-9. PubMed ID: 2258014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration, distribution and kinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human skin in vitro.
    Weber LW; Zesch A; Rozman K
    Arch Toxicol; 1991; 65(5):421-8. PubMed ID: 1929859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target tissue morphology and serum biochemistry following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain.
    Pohjanvirta R; Kulju T; Morselt AF; Tuominen R; Juvonen R; Rozman K; Männistö P; Collan Y; Sainio EL; Tuomisto J
    Fundam Appl Toxicol; 1989 May; 12(4):698-712. PubMed ID: 2744273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: analysis with a physiological modeling approach.
    Leung HW; Poland A; Paustenbach DJ; Murray FJ; Andersen ME
    Toxicol Appl Pharmacol; 1990 May; 103(3):411-9. PubMed ID: 2339414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCDD administered on activated carbon eliminates bioavailability and subsequent shifts to a key murine gut commensal.
    Stedtfeld RD; Brett Sallach J; Crawford RB; Stedtfeld TM; Williams MR; Waseem H; Johnston CT; Li H; Teppen BJ; Kaminski NE; Boyd SA; Tiedje JM; Hashsham SA
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7409-7415. PubMed ID: 28812142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.